Skip to main content
. 2022 Sep 16;7(38):34098–34108. doi: 10.1021/acsomega.2c03387

Table 2. Analytical Method Validation Data.

Parameter name EDTA BA CMN
System suitability
Tailing factor (<2.0) 1.3 1.2 0.9
Plate count (>2000) 50906 100154 75963
RSD% (n = 6 < 2.0) 0.3 0.4 0.8
Specificity
Diluent/Mobile phase Interference (Should be absent) No interference No interference No interference
Placebo interference (Should be absent) No Interference No Interference No Interference
Peak purity (Should be passed) Passed Passed Passed
Linearity
Range (μg/mL) 1.2–7.5 23.6–141.8 375–2250
Slope 139668 197415 239230
Intercept 102.05 349.85 756.46
Correlation coefficient >0.999 0.9999 0.9999 0.9994
LOQ (μg/mL) 0.04 0.03 0.02
Accuracy (n = 6 avg Percentage)
LOQ level ± SD 100.5 ± 0.3 100.8 ± 0.6 100.3 ± 0.9
80% mean ± SD 100.1 ± 0.5 99.6 ± 0.2 99.1 ± 0.6
100% mean ± SD 99.3 ± 1.1 99.9 ± 0.9 99.5 ± 0.4
120% mean ± SD 100.3 ± 1.1 99.3 ± 0.1 99.6 ± 1.5
Precision (Interday, n = 6 RSD% < 2.0) 0.5 0.4 0.6
Intermediate Precision (Intraday, n = 6 RSD% < 2.0) 0.8 0.8 0.8
Ruggedness (n = 12 RSD% < 2.0) 0.6 0.6 0.7
Solution stability B.T (0 and 24 h % difference <2.0) 0.3 0.5 0.8
Solution stability 2–8 °C (0 and 24 h % difference <2.0) 0.6 0.4 1.3
Solution stability B.T (0 and 48 h % difference <2.0) 1.3 0.5 1.6
Solution stability 2–8 °C (0 and 48 h % difference <2.0) 1.6 1.1 1.4